SLC45A4, or Solute Carrier Family 45 Member A4, is a protein that is part of the SLC45 family of transporters. Members of this family are known to transport diverse substrates across cellular membranes. SLC45A4 is embedded in cellular membranes, and its structure suggests that it functions to transport sugars or sugar-like molecules across these membranes, potentially playing a role in cellular energy management or the regulation of sugar concentrations within various compartments of the cell. Its expression pattern, which may vary across different tissues, could provide clues to its physiological roles.
As with other solute carriers, SLC45A4 presumably operates through a mechanism that involves the binding of its substrate in a specific conformation, followed by a conformational change that allows the substrate to be released on the other side of the membrane. This process could be either energy-independent, functioning through facilitated diffusion, or it could be an active transport process, requiring the input of energy, possibly in the form of ATP hydrolysis or the utilization of an electrochemical gradient.Disruptions in the function of SLC45 family members can have critical implications for cellular homeostasis. While no diseases have been conclusively linked to SLC45A4, mutations or dysregulation of solute carrier proteins can lead to a variety of disorders, often with systemic effects due to the fundamental nature of substrate transport in cellular metabolism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
A calcium channel blocker, affecting calcium transport across cell membranes. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
Inhibits sodium channels and transporters, affecting sodium balance and transport. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Inhibits Na+/K+-ATPase, affecting ion balance and transport across membranes. | ||||||
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $79.00 $174.00 $425.00 $530.00 $866.00 $1450.00 $2200.00 | 1 | |
A carbonic anhydrase inhibitor, used for various conditions involving ion transport. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
An HDAC inhibitor, which could affect gene expression, potentially influencing SLC45A4. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
An HDAC inhibitor, used in cancer therapy, might affect SLC45A4-related pathways. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Inhibits autophagy and lysosomal degradation, potentially affecting protein turnover related to SLC45A4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, could impact signaling pathways, potentially affecting SLC45A4. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, which might indirectly affect proteins involved in cell growth and survival. | ||||||